CIK 0001674930 · Accelerated filer
Fulgent Genetics, Inc.
Sign in to watch- Ticker
- FLGT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812621304
- Phone
- 626-350-0537
- Business address
- 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
- Former names
- Fulgent Diagnostics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $117,132
- in 4 filings
Net −$117,132. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-16 | Gao Hanlin Chief Scientific Officer | Sale | −311 | $95.50 | $30K | 815,648 |
| 2021-11-03 | Xie Jian Chief Operating Officer | Shares withheld for taxes | −5,904 | $88.12 | $520K | 304,553 |
| 2021-11-03 | KIM PAUL CFO and Treasurer | Shares withheld for taxes | −1,181 | $88.12 | $104K | 133,995 |
| 2021-11-01 | Xie Jian Chief Operating Officer | Shares withheld for taxes | −738 | $86.79 | $64K | 310,457 |
| 2021-09-10 | Hsieh Ming President and CEO | Other acquisition · Forward sale contract (obligation to sell) | +750,000 | 750,000 | ||
| 2021-09-02 | KIM PAUL CFO and Treasurer | Sale | −607 | $94.29 | $57K | 135,176 |
| 2021-08-30 | Xie Jian Chief Operating Officer | Sale | −622 | $91.25 | $57K | 311,195 |
| 2021-08-30 | BOLGER JOHN C Director | Option exercise | +312 | $3.93 | $1K | 2,312 |
| 2021-08-30 | BOLGER JOHN C Director | Sale | −312 | $91.38 | $29K | 2,000 |
| 2021-08-30 | BOLGER JOHN C Director | Option exercise | +312 | $15.82 | $5K | 2,312 |
| 2021-08-30 | BOLGER JOHN C Director | Sale | −312 | $91.05 | $28K | 2,000 |
| 2021-08-30 | BOLGER JOHN C Director | Option exercise | +312 | $5.81 | $2K | 2,312 |
| 2021-08-30 | BOLGER JOHN C Director | Sale | −312 | $91.44 | $29K | 2,000 |
| 2021-08-30 | BOLGER JOHN C Director | Option exercise · Stock Option (Right to Buy) | −312 | 938 | ||
| 2021-08-30 | BOLGER JOHN C Director | Option exercise · Stock Option (Right to Buy) | −312 | 2,188 | ||
| 2021-08-30 | BOLGER JOHN C Director | Option exercise · Stock Option (Right to Buy) | −312 | 3,438 | ||
| 2021-08-16 | Xie Jian Chief Operating Officer | Sale | −1,223 | $95.12 | $116K | 311,817 |
| 2021-08-16 | KIM PAUL CFO and Treasurer | Sale | −1,682 | $95.12 | $160K | 135,783 |
| 2021-08-16 | Gao Hanlin Chief Scientific Officer | Sale | −314 | $95.12 | $30K | 815,959 |
| 2021-08-03 | Xie Jian Chief Operating Officer | Shares withheld for taxes | −23,615 | $100.46 | $2.4M | 313,040 |
Page 22 of 23 · 453 trades